-
Symbol
-
ADAP
-
Investment type
-
Equity / Ordinary Shares, par value GBP 0.001 per share
-
Latest Disclosed Ownership
-
4 shares
-
Security Ownership
-
0%
New Enterprise Associates 14, L.P. ownership in Adaptimmune Therapeutics PLC Ordinary Shares, par value GBP 0.001 per share (ADAP)
2025-08-19 - New Enterprise Associates 14, L.P. has filed an SCHEDULE 13D/A form with the Securities and Exchange Commission (SEC) disclosing ownership of 4 shares of Adaptimmune Therapeutics PLC Ordinary Shares, par value GBP 0.001 per share (ADAP).
This represents 0% percent ownership of the company.